Treace Medical Concepts Inc

Treace Medical Concepts Inc

TMCI

Get informed when a big investor buys or sells

+ Follow
Market Cap$291.28M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Treace Medical Concepts IncTreace Medical Concepts Inc-4.8--88%1.50.2
$-1.38

Current Fair Value

130.4% downside

Overvalued by 130.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$291.28 Million
Enterprise Value$291.76 Million
Dividend Yield$- (-)
Earnings per Share$-0.93
Beta1.41
Outstanding Shares65,049,844

Return

Return on Equity-87.86%ROE
Return on Assets-32.87%
Return on Invested Capital-40.02%

Valuation & Multiples

P/E Ratio-4.83P/E Ratio
PEG55.08PEG
Price to Sales1.51Price to Sales
Price to Book Ratio4.54Price to Book Ratio
Enterprise Value to Revenue1.42
Enterprise Value to EBIT-5.22
Enterprise Value to Net Income-5
Total Debt to Enterprise0.04
Debt to Equity0.19Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 7, 2026
EPS Estimate
$-0.30
Average shareholder expectation
Revenue Estimate
$44.02 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 5, 2026
EPS Estimate
$-0.26
Average shareholder expectation
Revenue Estimate
$47.71 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls105,500▲ Infinity%
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %49.41%▼ 6.30%
Total Invested$127.94M▲ 164.88%
Investors Holding122▲ 5.00%

ESG Score

No data

About Treace Medical Concepts Inc

133 employees

Based in Ponte Vedra, FL, Treace Medical Concepts, Inc. is a privately-held medical device company focused on advancing the standard of care for the surgical management of bunion deformities. The Company’s patented Lapiplasty® 3D Bunion ...